News News
Typical MIM parts used in disposable surgical instruments and assembled in a clean room. (Image from Micro)Metal injection molding (MIM) works well for high-volume production of small, complex medical device parts of consistent quality.Demand for small, lightweight, high-strength, complex-shaped components is growing across industries today, from automotive, consumer electronics, aerospace and defense to orthodontics and medical devices.Traditional machining and injection molding each has its pros and cons in producing components for medical devices, especially where parts may be smaller and require more maneuverability. Metal injection molding (MIM) is a hybrid technology that integrates the shaping capability of plastic injection molding and the materials flexibility of conventional powd...
Relese time: 2019 - 08 - 15
Views:146
Non-location-specific, rapid provision of relevant data is essential for digital transformation in production. The ARBURG host computer system (ALS) offers new functions for mobile devices, such as mobile maintenance, which enables you to control and evaluate maintenance and service orders.
Relese time: 2018 - 11 - 27
Views:316
The Japanese MIM industry has reported its first growth in output for seven years, with sales rising to Yen 11.74 billion ($103.5 million) in 2017 – a healthy increase of 14.5% compared with the previous year.
Relese time: 2018 - 11 - 26
Views:201
3D CERAM-SINTO is one of the pioneers of additive printing technology for components made of technical ceramics and has extensive knowledge in terms of the process and the materials used in this field.
Relese time: 2018 - 11 - 19
Views:406
With additive manufacturing (AM) techniques being widely adopted in industries worldwide, design engineering and manufacturing are undoubtedly being ushered into a new era of development. But, how environmentally sustainable are AM materials?
Relese time: 2018 - 11 - 19
Views:387
Singapore / Ludwigshafen, Germany – November 6, 2018 – BASF launches  PeptAIde™, a sports nutrition ingredient containing a unique set of plant-based peptides identified using artificial intelligence (AI), for regulating inflammation. With industrial-scale production in Germany, PeptAIde is now available in the United States. Commercialization will follow in Asia Pacific and Europe by 2019. BASF is also currently performing regulatory clearance to allow access to other key markets.
Relese time: 2018 - 11 - 15
Views:287
Total45Pages7/9FirstPrev123456789NextLast
Share:
Uniris Exhibition Shanghai Co., Ltd.
Shanghai Branch 
Tel: 4000 778 909 
E-mail:irisexpo@163.com
Guangzhou Branch
Tel:020-8327 6389
Email:pmchina@unifair.com
PM CHINA Official Website
犀牛云提供企业云服务
Scan the QR code to visit the official website by phone